The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
A Randomised Controlled Trial Of Antivenom For Red-bellied Black Snake Envenoming
Funder
National Health and Medical Research Council
Funding Amount
$464,444.00
Summary
Muscle damage can result from snake bite, is irreversible and there is no specific treatment except antivenom. Red-bellied black snake bite provides a unique opportunity to study antivenom use in muscle damage in snake bite because this snake occurs across large population areas of NSW and Queensland. The study will determine if antivenom is effective and safe in red bellied black snake bite and whether it is therefore useful for other important snakes that cause muscle damage worldwide.
Prevention Of Drug Toxicities With Dichloroacetic Acid - The Implications For Cancer Chemotherapy
Funder
National Health and Medical Research Council
Funding Amount
$539,839.00
Summary
Many valuable cancer drugs have limited clinical use because of their toxic side effects. Our experiments with a new anti cancer drug called dichloroacetic acid (DCA) will determine if it can reduce the toxic effects of Cisplatin on the kidney and the effects of Doxorubicin on the heart.
A Randomized, Double-blinded Controlled Trial (RCT) Of A New Whole IgG, Equine Antivenom Compared To The Currently Used F(ab’)2 CSL Taipan Antivenom, For The Treatment Of Papuan Taipan (Oxyuranus Scutellatus) Envenoming In Papua New Guinea.
Funder
National Health and Medical Research Council
Funding Amount
$1,453,073.00
Summary
Snakebite is very common in Papua New Guinea (PNG), and many bites are caused by the Papuan taipan, a highly venomous snake found in the southern PNG savannah's. Current antivenom is expensive (US$1500) and many patients do not receive optimal treatment. We will conduct a randomised controlled trial of a new, low cost taipan antivenom developed specifically for PNG. The safety and efficacy of the new antivenom is compared to the existing product to determine if it is a suitable alternative.
Prevention Of Heart Damage During Anthracycline Cancer Chemotherapy
Funder
National Health and Medical Research Council
Funding Amount
$327,214.00
Summary
Doxorubicin is an effective medicine widely used for the treatment of cancer. However, it can cause heart damage, which not only creates a new health problem, but also limits the length of doxorubicin treatment cancer patients can receive, and therefore the likelihood of cancer cure. Preventing heart damage by doxorubicin is therefore important to improve overall cancer cure rates and patient health. This study aims to develop new medications to prevent heart damage during cancer chemotherapy.